Bayer AG's reported some encouraging third quarter developments in its consumer health business, including a return to OTC status for some brands in China. But much more will be needed to have confidence the business is on the way up.
Putting behind it a supply problem for its iconic Bayer Aspirin brand is among the key steps still needed to...


